Current issue Volume 6(4); October 2024

Sodium-glucose cotransporter 2 inhibitors in cardiocerebrovascular disease Jin Joo Park Cardiovasc Prev Pharmacother. 2024;6(4):103-108. Review ArticleOctober 31, 2024
Moyamoya disease: insights into the clinical implications of the RNF213 gene Taedong Ok Cardiovasc Prev Pharmacother. 2024;6(4):109-115. Review ArticleOctober 31, 2024
Paradigm shift from glucocentric to organ protection for the management of hyperglycemia in patients with type 2 diabetes Jie-Eun Lee, Jong Chul Won Cardiovasc Prev Pharmacother. 2024;6(4):116-122. Review ArticleOctober 31, 2024
Relationship between autonomic and peripheral neuropathies and cardiovascular outcomes in diabetes Jae-Seung Yun Cardiovasc Prev Pharmacother. 2024;6(4):123-127. Review ArticleOctober 31, 2024
Use of dual-energy x-ray absorptiometry for body composition in chronic disease management Tae Nyun Kim Cardiovasc Prev Pharmacother. 2024;6(4):128-134. Review ArticleOctober 31, 2024

MOST VIEWED

MOST CITED

Cardiovascular Prevention and Pharmacotherapy: ENDNOTE STYLE FILE METRICS

Recent Issues

TOP